{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:32:14Z","timestamp":1784748734523,"version":"3.55.0"},"publisher-location":"Cham","reference-count":79,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030648527","type":"print"},{"value":"9783030648534","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-64853-4_4","type":"book-chapter","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T08:02:46Z","timestamp":1617350566000},"page":"177-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Recent Advances in the Chemistry and Pharmacology of Cryptolepine"],"prefix":"10.1007","author":[{"given":"Steven D.","family":"Shnyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"4_CR1","first-page":"117","volume-title":"Natural products as future medicinal agents","author":"CW Wright","year":"2008","unstructured":"Wright CW (2008) Cryptolepine. In: Hawthorne S (ed) Natural products as future medicinal agents. Transworld Research Network, Kerala, India, p 117"},{"key":"4_CR2","unstructured":"The Plant List (2020) http:\/\/www.theplantlist.org\/"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/bmc.2985","volume":"27","author":"A Chatterjee","year":"2013","unstructured":"Chatterjee A, Kumar S, Chattopadhyay SK (2013) A validated HPLC-PDA method for identification of two bioactive alkaloids, ephedrine and cryptolepine, in different Sida species. Biomed Chromatogr 27:1720","journal-title":"Biomed Chromatogr"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1016\/j.tet.2006.04.050","volume":"62","author":"T Dhanabal","year":"2006","unstructured":"Dhanabal T, Sangeetha R, Mohan PS (2006) Heteroatom directed photoannulation: synthesis of indoloquinoline alkaloids: cryptolepine, cryptotackeine, cryptosanguinolentine, and their methyl derivatives. Tetrahedron 62:6258","journal-title":"Tetrahedron"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1570179412666150511224648","volume":"13","author":"PT Parvatkar","year":"2016","unstructured":"Parvatkar PT, Parameswaran PS (2016) Indoloquinolines: possible biogenesis from common indole precursors and their synthesis using domino strategies. Curr Org Synth 13:58","journal-title":"Curr Org Synth"},{"key":"4_CR6","unstructured":"Lavrado, J, Moreira R, Paulo A (2011) Synthetic strategies towards bioactive indolo[3,2-b]quinolines. In: Carreiras M do C, Marco-Contelles J (eds) Heterocyclic targets in advanced organic synthesis, vol 5. Research Signpost, Tivandrum, India, p 109"},{"key":"4_CR7","doi-asserted-by":"crossref","unstructured":"Volvoikar PS, Pravatkar PT, Tilve SG (2013) Tandem reductive cyclization-dehydration approach for the synthesis of cryptolepine hydroiodide and its analogues. Eur J Org Chem:2172","DOI":"10.1002\/ejoc.201201586"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"22481","DOI":"10.1039\/c4ra02814g","volume":"4","author":"PT Parvatkar","year":"2014","unstructured":"Parvatkar PT, Majik MS (2014) Microwave-assisted reductive cyclization: an easy entry to the indoloquinolines and spiro[2H-indole-2,3\u2032-oxindole]. RSC Adv 4:22481","journal-title":"RSC Adv"},{"key":"4_CR9","doi-asserted-by":"crossref","unstructured":"Holt SJ, Petrow V (1947) Carbazoles, carbolines and related compounds. Part 1. Quindoline derivatives. J Chem Soc:607","DOI":"10.1039\/jr9470000607"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/jm040893w","volume":"48","author":"O Onyeibor","year":"2005","unstructured":"Onyeibor O, Croft SL, Dodson HI, Feiz-Haddad M, Kendrick H, Millington NJ, Parapini S, Phillips RM, Seville S, Shnyder SD, Taramelli D, Wright CW (2005) Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities and consideration of their antimalarial mode of action. J Med Chem 48:2701","journal-title":"J Med Chem"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1016\/j.tet.2013.08.019","volume":"69","author":"B Bog\u00e1nyi","year":"2013","unstructured":"Bog\u00e1nyi B, K\u00e1m\u00e1n J (2013) A concise synthesis of indoloquinoline skeletons applying two consecutive Pd-catalyzed reactions. Tetrahedron 69:9512","journal-title":"Tetrahedron"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/adsc.201600410","volume":"358","author":"J Wippich","year":"2016","unstructured":"Wippich J, Truchan N, Bach T (2016) Rhodium catalyzed N-tert-butoxycarbonyl (Boc) amination by directed C-H bond activation. Adv Synth Catal 358:2083","journal-title":"Adv Synth Catal"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/molecules23040838","volume":"23","author":"K Yonekura","year":"2018","unstructured":"Yonekura K, Shinoda M, Yonekura Y, Tsuchimoto T (2018) Indium-catalyzed annulations of o-acylanilines with alkoxyheteroarenes: Synthesis of heteroaryl[b]quinoline and subsequent transformation to cryptolepine derivatives. Molecules 23:838","journal-title":"Molecules"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/slct.201803515","volume":"4","author":"VY Shuvalov","year":"2019","unstructured":"Shuvalov VY, Rupp AS, Kuratova AS, Fisyuk AS, Kuratova AK, Nefedov AA, Sagitullina GP (2019) Synthesis and optical properties of the alkaloid quindoline, its structural analogues and substituted \u03b4-carbolines. ChemistrySelect 4:1696","journal-title":"ChemistrySelect"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ptr.1284","volume":"17","author":"S Gibbons","year":"2003","unstructured":"Gibbons S, Fallah F, Wright CW (2003) Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta. Phytother Res 17:434","journal-title":"Phytother Res"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.compbiolchem.2017.01.003","volume":"67","author":"SR Appunni","year":"2017","unstructured":"Appunni SR, Rubens M, Chandana S, Singh HN, Swarup V (2017) Targeting PknB, an eukaryotic-like serine\/threonine protein kinase of Mycobacterium tuberculosis with phytomolecules. Comp Biol Chem 67:200","journal-title":"Comp Biol Chem"},{"key":"4_CR17","doi-asserted-by":"crossref","unstructured":"Gurung AB, Mylliemngap BJ, Battercharjee A, Ali MA Al-Hemaid FMA (2015) Interactome analysis and design of inhibitors against selected protein targets of Ser\/Thr protein kinse (STPK) signalling pathways in Mycobacterium tuberculosis H37Rv. Genet Mol Res 14:10390","DOI":"10.4238\/2015.September.1.6"},{"key":"4_CR18","doi-asserted-by":"crossref","unstructured":"Bolden S, Jr, Zhu XY, Etukala JR, Boateng C, Mazu T, Flores-Rozas H, Jacob MR, Khan SI, Walker LA Ablordeppy SY (2013) Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodides as anti-opportunistic infection agents. Eur J Med Chem 70:130","DOI":"10.1016\/j.ejmech.2013.09.044"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1016\/j.bmc.2013.08.043","volume":"21","author":"S Bolden","year":"2013","unstructured":"Bolden S, Boateng CA, Zhu ZY, Etukala JR, Eyunni SK, Jacob MR, Khan SI, Ablordeppy SY (2013) CoMFA studies and in vitro evaluation of some 3-substituted benzylthioquinolinium salts as cryptococcal agents. Bioorg Med Chem 21:7194","journal-title":"Bioorg Med Chem"},{"key":"4_CR20","doi-asserted-by":"crossref","unstructured":"Fernandes HD, Filomena B, Silvia L, Gabriel BC, Betuel S (2020) A systematic review of in vitro activity of medicinal plants from sub-Saharan Africa against Campylobacter spp. eCAM, 20209485364","DOI":"10.1155\/2020\/9485364"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"103062","DOI":"10.1016\/j.bioorg.2019.103062","volume":"90","author":"VJ Nuthakki","year":"2019","unstructured":"Nuthakki VJ, Mudududdla R, Sharma A, Kumar A, Bharate SB (2019) Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual chlolinesterase inhibitors. Bioorg Chem 90:103062","journal-title":"Bioorg Chem"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1021\/jm9704816","volume":"41","author":"DE Bierer","year":"1998","unstructured":"Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litva J, Lu Q, Zhang P, Reed MJ, Wladeck N, Bruening RC, Noamesi BK, Hector RF, Carlson TJ, King SR (1998) Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis and in vitro and in vivo activities. J Med Chem 41:894","journal-title":"J Med Chem"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1021\/jm970735n","volume":"41","author":"DE Bierer","year":"1998","unstructured":"Bierer DE, Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan P-W, Fort DM, Litvac J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM (1998) Antihyperglycaemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J Med Chem 41:2754","journal-title":"J Med Chem"},{"key":"4_CR24","first-page":"263","volume":"5","author":"EO Ameyaw","year":"2016","unstructured":"Ameyaw EO, Koffuor GA, Asare KK, Konja D, Du-bois A, Kyei S, Forkuo AD, Mensah RNAO (2016) Cryptolepine, an indoloquinoline alkaloid, in the management of diabetic mellitus and its associated complications. J Intercult Ethnopharmacol 5:263","journal-title":"J Intercult Pharm"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bmc.2006.10.018","volume":"15","author":"O Olajide","year":"2007","unstructured":"Olajide O, Heiss EH, Schachner D, Wright CW, Vollmar AM, Dirsch VM (2007) Synthetic cryptolepine inhibits DNA binding of NF-\u03baB. Bioorg Med Chem 15:43","journal-title":"Bioorg Med Chem"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/ptr.2794","volume":"23","author":"OA Olajide","year":"2009","unstructured":"Olajide OA, Ajayi AM, Wright CW (2009) Antiinflammatory properties of cryptolepine. Phytother Res 23:1421","journal-title":"Phytother Res"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejmech.2013.02.004","volume":"63","author":"OA Olajide","year":"2013","unstructured":"Olajide OA, Bhatia HS, de Oliveira ACP, Wright CW, Fiebich BL (2013) Anti-neuroinflammatory properties of synthetic cryptolepine in human neuroblastoma cells: possible involvement of NF-\u03baB and p38 MAPK inhibition. Eur J Med Chem 63:333","journal-title":"Eur J Med Chem"},{"key":"4_CR28","doi-asserted-by":"crossref","unstructured":"Olajide OA, Bhatia HS, de Oliveira ACP, Wright CW, Fiebich BL (2013) Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine. eCAM 459723","DOI":"10.1155\/2013\/459723"},{"key":"4_CR29","unstructured":"Cimanga KR, Malika BMF, Kambu KO, Tona LG, Vlietinck AJ, Pieters L (2018) Assessment of acute and subacute toxicity of extracts and in vitro susceptibility of extracts and isolated indoloquinoline alkaloids from Cryptolepis sanguinolenta (Lindl.) Schlechter (Periplocaceae) root bark to Entamoeba histolytica. World J Pharm Pharm Sci 7:183"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1039\/C9RA09905K","volume":"10","author":"D Orozco","year":"2020","unstructured":"Orozco D, Kounznetsov VV, Bermudez A, Vargas Mendez LY, Salgado ARM, Gomez CMM (2020) Recent synthetic efforts in the preparation of 2-(3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agents. RSC Adv 10:4876","journal-title":"RSC Adv"},{"key":"4_CR31","doi-asserted-by":"crossref","unstructured":"Sengupta S, Chowdhury S, Bose Dasgupta S, Wright CW, Majumder HK (2011) Cryptolepine-induced cell-death of Leishmania donovani promastigotes is augmented by inhibition of autophagy. Mol Biol Int 187850","DOI":"10.4061\/2011\/187850"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00436-012-2818-9","volume":"111","author":"S Hazra","year":"2012","unstructured":"Hazra S, Ghosh S, Debnath S, Seville S, Prajapati VK, Wright CW, Sundar S, Hazra B (2012) Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes. Parasitol Res 111:195","journal-title":"Parasitol Res"},{"key":"4_CR33","unstructured":"World Health Organisation (2019) World malaria report. www.who.int"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.1215966","volume":"336","author":"IH Cheesman","year":"2012","unstructured":"Cheesman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJC (2012) A major genome region underlying artemisinin resistance in malaria. Science 336:79","journal-title":"Science"},{"key":"4_CR35","doi-asserted-by":"crossref","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455","DOI":"10.1056\/NEJMoa0808859"},{"key":"4_CR36","doi-asserted-by":"crossref","unstructured":"Bugyei, KA, Boye GL Addy ME (2010) Cinical efficacy of a tea-bag formulation of Cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria. Ghana Med J 44:3","DOI":"10.4314\/gmj.v44i1.68849"},{"key":"4_CR37","first-page":"58","volume":"4","author":"A Mensah","year":"2017","unstructured":"Mensah A, Kuntworbe N, Johnson R, Ofori-Kwakye K (2017) Qualitative and quantitative assessment of Cryptolepis-based formulations within the Accra and Kumasi metropolis in Ghana. JIPBS 4:58","journal-title":"JIPBS"},{"key":"4_CR38","doi-asserted-by":"crossref","unstructured":"Amissah JN, Osei-Safo D, Asare C M, Missah-Assihene B, Danquah, EY, Addae-Mensah I (2016) Influence of age and staking on the growth and cryptolepine concentration in cultivated roots of Cryptolepis sanguinolenta (Lindl.) Schlt. JMPR 10:113","DOI":"10.5897\/JMPR2015.5793"},{"key":"4_CR39","doi-asserted-by":"crossref","unstructured":"Wright CW, Phillipson JD, Awe SO, Kirby GC, Warhurst DC, Quetin-Leclerq J Angenot L (1996) Antimalarial activity of cryptolepine and some other anhydronium bases. Phytother Res 10:361","DOI":"10.1002\/(SICI)1099-1573(199606)10:4<361::AID-PTR845>3.0.CO;2-N"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1021\/jm010929+","volume":"44","author":"CW Wright","year":"2001","unstructured":"Wright CW, Addae-Kyereme J, Breen AG, Brown JE, Cox MF, Croft SL, G\u00f6k\u00e7ek Y, Kendrick H, Phillips RM, Pollet PL (2001) Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. J Med Chem 44:3187","journal-title":"J Med Chem"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1021\/bi972927q","volume":"37","author":"K Bonjean","year":"1998","unstructured":"Bonjean K, De Pauw-Gillet MC, Defresne MP, Colson P, Houssier C, Dassoneville L, Bailly C, Greimers R, Wright C, Quetin-Leclercq J, Tits M, Angenot L (1998) The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry 37:5136","journal-title":"Biochemistry"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nsb729","volume":"9","author":"JN Lisgarten","year":"2002","unstructured":"Lisgarten JN, Coll M, Portugal J, Wright CW, Aymami J (2002) The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. Nat Struct Biol 9:57","journal-title":"Nat Struct Biol"},{"key":"4_CR43","doi-asserted-by":"crossref","unstructured":"Forkuo AD, Ansah C, Mensah KB, Annan K, Gyan, B, Theron A Mancama D, Wright CW (2017) In vitro antimalarial interaction and gametocytocidal activity of cryptolepine. Malaria J 16:496","DOI":"10.1186\/s12936-017-2142-z"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nrd2972","volume":"8","author":"TNC Wells","year":"2009","unstructured":"Wells TNC, Alonso PL, Gutteridge WE (2009) New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov 8:879","journal-title":"Nat Rev Drug Discov"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12936-016-1137-5","volume":"15","author":"AD Forkuo","year":"2016","unstructured":"Forkuo AD, Ansah C, Boadu KM, Boampong JN, Ameyaw EO, Gyan BA, Arku AT, Ofori MF (2016) Synergistic anti-malarial action of cryptolepine and artemisinins. Malaria J 15:89","journal-title":"Malaria J"},{"key":"4_CR46","doi-asserted-by":"crossref","unstructured":"Ameyaw EO, Asmah KB, Biney RP, Henneh IT, Owusu-Agyei P, Prah J, Forkuo AD 2018. Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei infected mice. Malaria J 17:153\/1","DOI":"10.1186\/s12936-018-2283-8"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1021\/jm101383f","volume":"54","author":"J Lavrado","year":"2011","unstructured":"Lavrado J, Cabal GG, Prud\u00eancio M, Mota MM, Gut J, Rosenthal PJ, Diaz C, Guedes RC, dos Santos DJVA, Bichenkova E, Douglas KT, Moreira R, Paulo A (2011) Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies. J Med Chem 54:734","journal-title":"J Med Chem"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/mrc.2873","volume":"50","author":"J Lavrado","year":"2012","unstructured":"Lavrado J, Paulo A, Bichenkova E, Douglas KT, Moreira R (2012) 1H NMR spectroscopic identification of protonable sites in cryptolepines with C-11 substituents containing two amino functionalities. Mag Reson Chem 50:216","journal-title":"Mag Reson Chem"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00894-011-1009-4","volume":"17","author":"H Behzadi","year":"2011","unstructured":"Behzadi H, Olai MRTB, van der Spoel D (2011) Probing 13C chemical shielding tensors in cryptolepine and two bromo-substituted analogs for antiplasmodial activity. J Mol Mod 17:3289","journal-title":"J Mol Mod"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1002\/cmdc.201800579","volume":"13","author":"R Mududdla","year":"2018","unstructured":"Mududdla R, Mohankrishnan D, Bharate SS, Vishwakarma RA, Sahal D, Bharate SB (2018) Orally effective aminoalkyl 10H-indolo[3,2-b]quinoline-11-carboxamide kills the malaria parasite by inhibiting host haemoglobin uptake. ChemMedChem 13:2581","journal-title":"ChemMedChem"},{"key":"4_CR51","unstructured":"Abacha YZ (2020) Investigation of Nigerian ethnomedicinal plants as potential sources of cytotoxic and antiplasmodial compounds. PhD thesis, University of Bradford, Bradford, UK, p 165"},{"key":"4_CR52","first-page":"193","volume":"4","author":"AJ Oluwafemi","year":"2009","unstructured":"Oluwafemi AJ, Okanla EO, Camps P, Mu\u00f1oz-Torrero D, Mackey ZB, Chiang PK, Seville S, Wright CW (2009) Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis. Nat Prod Commun 4:193","journal-title":"Nat Prod Commun"},{"key":"4_CR53","first-page":"57","volume":"11","author":"AJ Arguelles","year":"2016","unstructured":"Arguelles AJ, Cordell GA, Maruenda H (2016) Molecular docking and binding mode analysis of plant alkaloids as in vitro and in silico inhibitors of trypanothione reductase from Trypanosoma cruzi. Nat Prod Commun 11:57","journal-title":"Nat Prod Commun"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1016\/j.bmcl.2012.07.104","volume":"22","author":"J Lavrado","year":"2012","unstructured":"Lavrado J, Mackey Z, Hansell E, McKerrow JH, Paulo A, Moreira R (2012) Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives. Bioorg Med Chem Lett 22:6256","journal-title":"Bioorg Med Chem Lett"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1166\/jctn.2015.4042","volume":"12","author":"S Belaidi","year":"2015","unstructured":"Belaidi S, Salah T, Ndjib M, Sinha L, Prasad O (2015) Structure activity relationships modeling of antitrypanosomal activities of alkyldiamine derivatives. J Comput Theor Nanosci 12:2421","journal-title":"J Comput Theor Nanosci"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41598-017-01659-7","volume":"7","author":"HC Pal","year":"2017","unstructured":"Pal HC, Prasad R, Katiyar SK (2017) Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPK\u03b11\/2-LKB1. Sci Rep 7:1498","journal-title":"Sci Rep"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2019.02.072","volume":"169","author":"JM Yuan","year":"2019","unstructured":"Yuan JM, Wei K, Zhang GH, Chen NY, Wei XW, Pan CX, Mo DL, Su GF (2019) Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis. Eur J Med Chem 169:144","journal-title":"Eur J Med Chem"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1039\/D0CC00524J","volume":"56","author":"QP Qin","year":"2020","unstructured":"Qin QP, Wei ZZ, Wang ZF, Huang XL, Tan MX, Zou HH, Liang H (2020) Imaging and therapeutic applications of Zn(II)-cryptolepine-curcumin molecular probes in cell apoptosis detection and photodynamic therapy. Chem Commun 56:3999","journal-title":"Chem Comm"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s10637-008-9185-5","volume":"27","author":"D Laryea","year":"2009","unstructured":"Laryea D, Isaksson A, Wright CW, Larsson R, Nygren P (2009) Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumor cell lines and primary cultures of tumor cells from patients. Invest New Drugs 27:402","journal-title":"Invest New Drugs"},{"key":"4_CR60","first-page":"137","volume":"47","author":"C Ansah","year":"2013","unstructured":"Ansah C, Mensah KB (2013) A review of the anticancer potential of the antimalarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Ghana Med J 47:137","journal-title":"Ghana Med J"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ptr.3219","volume":"25","author":"F Ahmed","year":"2011","unstructured":"Ahmed F, Toume K, Ohtsuki T, Rahman M, Sadhu SK, Ishibashi M (2011) Cryptolepine, isolated from Sida acuta, sensitizes human gastric adenocarcinoma cells to TRAIL-induced apoptosis. Phytother Res 25:147","journal-title":"Phytother Res"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/molecules21121758","volume":"21","author":"HC Pal","year":"2016","unstructured":"Pal HC, Katiyar SK (2016) Cryptolepine, a plant alkaloid, inhibits the growth of non-melanoma skin cancer cells through inhibition of topoisomerase and induction of DNA damage. Molecules 21:1758","journal-title":"Molecules"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1039\/b409698c","volume":"2","author":"S Ladame","year":"2004","unstructured":"Ladame S, Schouten JA, Stuart J, Roldan J, Neidle S, Balasubramanian S (2004) Tetrapeptides induce selective recognition for G-quadruplexes when conjugated to a DNA-binding platform. Org Biomol Chem 2:2925","journal-title":"Org Biomol Chem"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/bc300123m","volume":"23","author":"Y Long","year":"2012","unstructured":"Long Y, Li Z, Tan JH, Ou TM, Li D, Gu LQ, Huang ZS (2012) Benzofuroquinoline derivatives had remarkable improvement of their selectivity for telomeric G-quadruplex DNA over duplex DNA upon introduction of peptidyl group. Bioconjug Chem 23:1821","journal-title":"Bioconjug Chem"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1016\/j.bmcl.2010.09.110","volume":"20","author":"J Lavrado","year":"2010","unstructured":"Lavrado J, Reszka AP, Moreira R, Neidle S, Paulo A (2010) C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization. Bioorg Med Chem Lett 20:7042","journal-title":"Bioorg Med Chem Lett"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/cmdc.201300288","volume":"8","author":"J Lavrado","year":"2013","unstructured":"Lavrado J, Borralho PM, Ohnmacht SA, Castro RE, Rodrigues CM, Moreira R, dos Santos DJ, Neidle S, Paulo A (2013) Synthesis, G-quadruplex stabilization, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains. ChemMedChem 8:1648","journal-title":"ChemMedChem"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/13880209.2012.738424","volume":"51","author":"FH Shen","year":"2013","unstructured":"Shen FH, Jin J, Li J, Wang Y, Zhu SH, Lu YJ, Ou TM, Huang ZS, Huang M, Huang ZY (2013) The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells. Pharm Biol 51:447","journal-title":"Pharm Biol"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1039\/C5OB02408K","volume":"14","author":"A Le Gresley","year":"2016","unstructured":"Le Gresley A, Gudivaka V, Carrington S, Sinclair A, Brown JE (2016) Synthesis, analysis and biological evaluation of novel indolquinonecryptolepine analogues as potential anti-tumour agents. Org Biomol Chem 14:3069","journal-title":"Org Biomol Chem"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.5732\/cjc.009.10203","volume":"28","author":"WJ Zhou","year":"2009","unstructured":"Zhou WJ, Deng R, Feng GK, Zhu XF (2009) A G-quadruplex ligand SYUIQ-5 induces autophagy by inhibiting the Akt-FOXO3, a pathway in nasopharyngeal cancer cells. Chin J Cancer 28:1049","journal-title":"Chin J Cancer"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3109\/10837450.2012.668554","volume":"18","author":"N Kuntworbe","year":"2013","unstructured":"Kuntworbe N, Alany RG, Brimble M, Al-Kassas R (2013) Determination of pKa and forced degradation of the indoloquinoline antimalarial compound cryptolepine hydrochloride. Pharm Dev Tech 18:866","journal-title":"Pharm Dev Tech"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.56499\/jppres17.359_6.4.260","volume":"6","author":"RA Kwakye","year":"2018","unstructured":"Kwakye RA, Kuntworbe N, Ofori-Kwakye K, Osei YA (2018) Detection, quantification and investigation of the red blood cell partitioning of cryptolepine hydrochloride. J Pharm Pharmacogn Res 6:260","journal-title":"J Pharm Pharmacogn Res"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.2042-7158.2011.01408.x","volume":"64","author":"JGP Stell","year":"2011","unstructured":"Stell JGP, Wheelhouse RT, Wright CW (2011) Metabolism of cryptolepine and 2-fluorocryptolepine by aldehyde oxidase. J Pharm Pharmac 64:237","journal-title":"J Pharm Pharmac"},{"key":"4_CR73","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40360-017-0188-8","volume":"18","author":"AD Forkuo","year":"2017","unstructured":"Forkuo AD, Ansah C, Pearson D, Gertsch W, Cirello A, Amaral A, Spear J, Wright CW, Rynn C (2017) Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats. BMC Pharmacol Toxicol 18:84","journal-title":"BMC Pharmacol Toxicol"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1128\/AAC.00532-08","volume":"52","author":"M Rojas","year":"2008","unstructured":"Rojas M, Wright CW, Pi\u00f1a B, Portugal J (2008) Genomewide expression profiling of cryptolepine-induced toxicity in Saccharomyces cerevisiae. Antimicrob Agents Chemother 52:3844","journal-title":"Antimic Agents Chemother"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tox.2004.11.026","volume":"298","author":"C Ansah","year":"2005","unstructured":"Ansah C, Khan A, Gooderham NJ (2005) In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Toxicology 298:141","journal-title":"Toxicology"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.toxlet.2011.09.010","volume":"207","author":"R Gopalan","year":"2011","unstructured":"Gopalan R, Emerce E, Wright CW, Karahalil B, Larakaya AE, Anderson D (2011) Effects of the anti-malarial compound cryptolepine and its analogues in human lymphocytes and sperm in the Comet assay. Toxicol Lett 207:322","journal-title":"Toxicol Lett"},{"key":"4_CR77","doi-asserted-by":"crossref","unstructured":"Mensah KB, Benneh C, Forkuo AD, Ansah C (2019) Cryptolepine, the\u00a0main\u00a0alkaloid\u00a0of the\u00a0antimalarial\u00a0Cryptolepis sanguinolenta (Lindl.) Schlechter, induces malformations in zebrafish embryos. Biochem Res Int 2019:7076986","DOI":"10.1155\/2019\/7076986"},{"key":"4_CR78","first-page":"10255","volume":"19","author":"IFA Mariz","year":"2017","unstructured":"Mariz IFA, Pinto S, Lavrado J, Paulo A, Martinho JMG, Ma\u00e7\u00f4as EMS (2017) Cryptolepine and quindoline: understanding their photophysics. PhysChem Chem Phys 19:10255","journal-title":"PhysChem Chem Phys"},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cphc.201501011","volume":"17","author":"RK Koninti","year":"2016","unstructured":"Koninti RK, Sappati S, Satpathi S, Gavvala K, Hazra P (2016) Spectroscopy and dynamics of cryptolepine in the nanocavity of cucurbit[7]uril and DNA. ChemPhysChem 17:506","journal-title":"ChemPhysChem"}],"container-title":["Progress in the Chemistry of Organic Natural Products","Progress in the Chemistry of Organic Natural Products 115"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-64853-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T11:35:08Z","timestamp":1724758508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-64853-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030648527","9783030648534"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-64853-4_4","relation":{},"ISSN":["2191-7043","2192-4309"],"issn-type":[{"value":"2191-7043","type":"print"},{"value":"2192-4309","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"3 April 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}